Back to Search
WILLIAM BUSSE, MD
MD
Allergy & Immunology (Internal Medicine) Physician
NPI: 1881661486Individual
Specialties, Licenses & Credentials
Allergy & Immunology (Internal Medicine) PhysicianPrimary
Internal Medicine — Allergy & Immunology
Code: 207RA0201X
16121(WI)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
PMID 32298853·J Allergy Clin Immunol Pract·2020
8-other
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
PMID 21410369·N Engl J Med·2011
4-observational
Prevalence of asthma and asthma-like symptoms in inner-city schoolchildren.
PMID 15801322·J Asthma·2005
8-other
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
PMID 15180756·Allergy·2004
3-trial
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
PMID 11496232·J Allergy Clin Immunol·2001
3-trial
Host immune responses to rhinovirus: mechanisms in asthma.
PMID 19014757·J Allergy Clin Immunol·2008
6-review
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.
PMID 18787222·Am J Respir Crit Care Med·2008
2-rct
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
PMID 18455221·J Allergy Clin Immunol·2008
3-trial
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.
PMID 18405951·J Allergy Clin Immunol·2008
2-rct
Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
PMID 17711616·Curr Med Res Opin·2007
3-trial
Addressing issues of asthma in inner-city children.
PMID 17208585·J Allergy Clin Immunol·2007
6-review
Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
PMID 16440534·Ann Allergy Asthma Immunol·2006
4-observational
Investigative bronchoprovocation and bronchoscopy in airway diseases.
PMID 16020805·Am J Respir Crit Care Med·2005
6-review
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
PMID 15821210·Chest·2005
6-review
Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
PMID 15598475·Clin Ther·2004
3-trial
Future research directions in asthma: an NHLBI Working Group report.
PMID 15215155·Am J Respir Crit Care Med·2004
6-review
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
PMID 12532097·J Allergy Clin Immunol·2003
3-trial
Anti-immunoglobulin E for the treatment of allergic disease.
PMID 11964677·Curr Opin Allergy Clin Immunol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5510 S HILL DR
MADISON, WI 53705 - Phone
- (000) 000-0000
Quick Facts
- NPI
- 1881661486
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile